Farmak JSC took part in the press briefing on Charitable Medical Kit held on 11 June 2015. The event was organized by the Ministry of Social Policy of Ukraine and Contribution to Medicine Development International Charitable Fund.
The press briefing was held in Kyiv Medical Social Center, Contribution to Medicine Development International Charitable Fund, on assistance to the people in emergency situations and families of internally displaced persons. The event was devoted to the results of Charitable Medical Kit campaign, started on 8 May 2015 under the aegis of the Ministry of Social Policy. Three Ukrainian pharmaceutical companies, including amongst Farmak JSC, a leader of Ukrainian pharmaceutical market, took part in the event.
Thanks to the charity activities of Ukrainian pharmaceutical companies within the framework of the campaign, at present, over 5 thousand of Charitable Medical Kits with over-the-counter medicines are formed and being delivered, through volunteers and charity organizations, to internally displaced families.
The Charitable Medical Kits are delivered to the families, residing in Chernigiv, Donetsk (Sloviansk), and Luhansk (Sievierodonetsk) regions.
Oleksiy Yatsyuk, Corporate Social Responsibility Manager, Farmak JSC, says, “Farmak, jointly with the other members of Manufacturers of Medications of Ukraine Association, determined to take part in the Charitable Medical Kit campaign. We have provided the medicinal products to the amount of nearly UAH 1 million. That was the first stage of the project. At present, the second stage – assistance to hospices in various regions of Ukraine (a total of 10 hospices), is being actively implemented. Farmak participates in the mentioned within the framework of its permanent charity activities.
Farmak Charitable Fund was established in 2011 to provide the charity activities and ensure control for the charity assistance to reach the ultimate recipients. At present, the Fund provides the charity activities in such areas as assistance to educational institutions and orphanages, health-care establishments and patients, cultural establishments, support and assistance to the troops in the anti-terrorist operation (ATO) zone and internally displaced persons”.
The pharmaceutical company JSC “Farmak” considers the possibility of launching the manufacture of products, in particular, diagnostic test kits, to combat coronavirus spread. “Now we analyse the possibility of arranging the release of supportive care products, disinfectants and antiseptics, diagnostic test kits, protective medical products, including masks, ...
Farmak reinvests 95% of its profits in the development. “We have never paid more than 5% of our profits as dividends. We have reinvested everything in the development. Due to this, Farmak’s capitalization can be estimated at $850 million to $1 billion today. If I sell the shares that I hold, I will earn a […]
The Memorandum is aimed at developing the mutual cooperation in the implementation of the state programs of the Republic of Uzbekistan for the further development of the national pharmaceutical industry. “We know the Uzbek market well and we are committed to develop cooperation. Farmak has been present in Uzbekistan since 2004. The residents of this [&hellip...